INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A.

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

01/01/1997

VAT status

Active

Bankruptcy proceedings

No proceedings

INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A.

Contacts

Registered address

See on map

Website

WWW.BIOMED.PL

Highest

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Incorporation date

18/01/2002

Share capital

8,032,700.00 PLN

Primary activity

Manufacture of pharmaceutical preparations (21.20.Z - PKD 2007)

Representatives

Representatives rights

DO SKŁADANIA OŚWIADCZEŃ WOLI I PODPISYWANIA W IMIENIU SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM.

Representatives

Chairman of the management boardA*** F***

Supervisory authority memberGrzegorz Andrzej Rak

Business linkages

Check business linkages of INSTYTUT BIOTECHNOLOGII SUROWIC I S...Check business linkages of a natural personCheck business linkages chain between 2 subjects

Price: zł63.00 | 1.00 credit

Compliance screening

Check whether your partner is listed in sanctions or PEP registers, or linked to negative public information or law enforcement reports. Ensure business safety and compliance.

Order report

Price: zł76.22 | 1.00 credit

People

Representatives

Person	Title
A* F*	Chairman of the management board
Grzegorz Andrzej Rak	Supervisory authority member

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

57,160,766

Net Profit (zł)

57,160,766

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
88,544,275
17,030,736
10,119,719
0.73
10.61
11.43
405,251,740
6,746,264
45,000
18,755,060

2023
108,204,590
46,695,210
38,150,615
0.63
5.41
35.26
610,887,736
15,515,275
30,000
20,197,487

2024
127,191,447
68,081,248
57,160,766
0.57
6.18
44.94
698,924,893
14,000,023
15,000
-

2024
127,191,447
68,081,248
57,160,766
0.57
6.18
44.94
698,924,893
14,000,023
15,000
-

Turnover (zł)

2024

Turnover (zł)

127,191,447 zł18 % *

Profit before tax (zł)

68,081,248 zł46 % *

Net Profit (zł)

57,160,766 zł50 % *

Working capital requirement (%)

0.57 -9.52 % *

Liquidity ratio

6.18 14.23 % *

Net profitability (%)

44.94 %27.45 % *

Equity (zł)

698,924,893 zł14 % *

Current liabilities (zł)

14,000,023 zł-10 % *

Non current liabilities (zł)

15,000 zł-50 % *

Non-current Assets (zł)

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Order report

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. Documents

Date	Description
03/07/2025	OD 01.01.2024 DO 31.12.2024
19/06/2024	OD 01.01.2023 DO 31.12.2023
30/06/2023	OD 01.01.2022 DO 31.12.2022
28/07/2022	OD 01.01.2021 DO 31.12.2021
25/06/2021	OD 01.01.2020 DO 31.12.2020

Frequently Asked Questions

What is the current status of INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A.?

INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. is currently Active. It was registered on 18/01/2002.

Where is INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. located?

INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. is registered at AL.SOSNOWA 8, 30-224, KRAKÓW, POLSKA.

What does INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. do?

INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. operates in the Manufacture of pharmaceutical preparations (21.20.Z - PKD 2007) sector.

What is the annual turnover of INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A.?

INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. reported a turnover of 127,191,447 PLN in 2024.

What is the net profit of INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A.?

INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. reported a net profit of 57,160,766 PLN in 2024.

Is INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. a reliable company?

INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. Pre-Score* rating is A, which indicates the highest level of reliability.

* The credit score is calculated based on financial data, payment history, and other risk indicators.

Does INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. have any unpaid debts?

INSTYTUT BIOTECHNOLOGII SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA AKCYJNA - SKRÓT FIRMY IBSS BIOMED S.A. has no recorded unpaid debts.